oncology

Showing 15 posts of 328 posts found.

J&J sign deal with Scottish firm AdoRx to develop novel lung cancer treatments

March 1, 2019
Medical Communications AdoRx, Cancer, Cancer Immunotherapy, J&J, JJ, immunology, oncology

Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel …

Nearly half of childhood cancer cases go untreated and undiagnosed

March 1, 2019
Medical Communications Cancer, childhood cancer, diagnosis, oncology, pediatric, world

Almost half of all children with cancer are going untreated and undiagnosed, according to research published in Lancet Oncology. While …

US Department of Justice investigate J&J over Baby Powder allegations

February 22, 2019
Medical Communications Cancer, J&J, JJ, Johnson and Johnson, USA, asbestos, oncology, talc

The Justice Department and US Securities and Exchanges Commission are investigation healthcare giant Johnson & Johnson over allegations that Johnson’s …

Smoking may limit immune system’s ability to fight cancer, study shows

February 18, 2019
Sales and Marketing Cancer, cancer research, immune system, immunology, melanoma, oncology, smoking

Smoking may limit the body’s ability to fight melanoma, according to a study published in the journal Cancer Research. The …

merckwindow_web

MSD’s Keytruda combo therapy significantly improves survival in advanced renal cell carcinoma

February 18, 2019
Sales and Marketing Cancer, MSD, Merck Sutent, Pfizer, inlyta, keytruda, oncology, rcc, renal cell carcinoma

Merck & Co’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib) significantly extended the lives of those with advanced renal …

101817_tumorsmyeloidsuppressorcells

Researchers find new type of cell membrane which causes cancer cells to explode

February 13, 2019
Research and Development Cancer, FTY720, cell membranes, molecules, oncology

Researchers at the Medical University of South Carolina (MUSC) have discovered a new type of cell membrane complex which causes …

image_credit_-_rafael_matsunaga

Clinigen shares soar after $210m Novartis cancer drug deal

February 13, 2019
Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology

British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …

genentech_web

Genentech to develop ‘highly active cytokine’ with Xancor in deal worth $300m

February 6, 2019
Research and Development Cancer, Genetech, IL-15 cytokine, Roche, Xancor, oncology

Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …

acute_lymphoblastic_leukaemia_smear

Obesity-related cancers on the rise amongst millennials

February 4, 2019
Sales and Marketing Cancer, obesity, oncology, young people

Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …

cancer-cells-541954_960_720

Israeli biotech claims it has developed cure for cancer

January 30, 2019
Research and Development Cancer, MuTaTo, biotech, israel, lung cancer, oncology

An Israeli biotech has claimed that it has developed a complete cure for cancer. Speaking to the Jerusalem Post, Dan …

Diagnosis at stages 1-3 increases cancer survival rate significantly

January 25, 2019
Medical Communications Cancer, England, NHS, health, oncology

Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following …

gsk_rd_harlow

GSK acquires oncology firm Tesaro for $5.1 billion

January 23, 2019
Research and Development Cancer, GSK, Tesaro, oncology, ovarian cancer

British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …

novartis_window

Canada Health approves Novartis’ CAR-T therapy Kymriah

January 18, 2019
Medical Communications CAR T, CAR-T, Canada, Cancer, Kymriah, Novartis, oncology

Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and …

More young people surviving cancer in England, despite significant economic divide

January 17, 2019
Medical Communications, Research and Development Cancer, England, UK, health public health, oncology, young people

Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …

The Gateway to Local Adoption Series

Latest content